Dambkowski Carl's Form 4 filing
Oruka Therapeutics, Inc. (ORKA) · filed May 22, 2026
- Accession no.
- 0000907654-26-000043
- Filed
- May 22, 2026
- Trade date
- May 21, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $6.19M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dambkowski CarlCIK 0001983476 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2026 | Common Stock | MOption exerciseAcquired | +38,689 | $6.84 | +$264,632.76 | 155,172 | Direct | |
| May 21, 2026 | Common Stock | MOption exerciseAcquired | +11,904 | $7.80 | +$92,851.2 | 167,076 | Direct | |
| May 21, 2026 | Common Stock | MOption exerciseAcquired | +11,667 | $11.77 | +$137,320.59 | 178,743 | Direct | |
| May 21, 2026 | Common Stock | SSaleDisposed | −38,318 | $58.43 | −$2,238,920.74 | 140,425 | Direct | |
| May 21, 2026 | Common Stock | SSaleDisposed | −53,447 | $59.10 | −$3,158,717.7 | 86,978 | Direct | |
| May 21, 2026 | Common Stock | SSaleDisposed | −13,235 | $59.97 | −$793,702.95 | 73,743 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2026 | Common Stock | MOption exerciseDisposed | −38,689 | $0.00 | $0 | 32,737 | Direct | |
| May 21, 2026 | Common Stock | MOption exerciseDisposed | −11,904 | $0.00 | $0 | 10,952 | Direct | |
| May 21, 2026 | Common Stock | MOption exerciseDisposed | −11,667 | $0.00 | $0 | 5,833 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.